Has Rachel Vantries received payments from drug or device companies?

Yes. Drug and device makers reported $3,150 in general payments to Rachel Vantries across 137 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachel Vantries did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachel Vantries come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachel Vantries

Physician Assistant · Indianapolis, INNPI 1700537461

Payments from drug & device makers

$3,150in general payments, 2019–2025

Across 137 payments — averaging $22.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vanda Pharmaceuticals Inc.$706
AbbVie$530
Tris Pharma Inc$349
Johnson & Johnson$174
Corium, LLC$168
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$158
plus $1K from 19 others

What the payments were for

Food & beverage$3,150100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vanda Pharmaceuticals Inc.	25	$706
AbbVie	29	$530
Tris Pharma Inc	15	$349
Johnson & Johnson	5	$174
Corium, LLC	7	$168
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	9	$158
Almatica Pharma LLC	8	$144
Axsome Therapeutics, Inc.	6	$140
Supernus Pharmaceuticals, Inc.	1	$113
Hologic Sales And Service, LLC	3	$98
Otsuka America Pharmaceutical, Inc.	4	$78
Otsuka Pharmaceutical Development & Commercialization, Inc.	3	$69
Collegium Pharmaceutical, Inc.	3	$64
Alkermes, Inc.	3	$60
Ironshore Pharmaceuticals Inc.	3	$52
Vertical Pharmaceuticals, LLC	3	$44
Mayne Pharma Commercial LLC	1	$37
Exeltis, USA Inc.	2	$33
Biogen	1	$24
Neos Therapeutics, LP	1	$22
Coopersurgical, Inc.	1	$20
Neurocrine Biosciences, Inc.	1	$18
Galderma Laboratories, L.p.	1	$18
Axonics, Inc.	1	$16
Organon	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Fanapt$233
SPRAVATO$119
QELBREE$113

How this compares

$3,150 in reported general payments places this provider in the 90th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VyvanseLisdexamfetamine Dimesylate	27	$9,306
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	13	$2,003
Alprazolam	14	$57
Clonazepam	21	$33

Paid to pharmacies, not to this prescriber.

Other physician assistant in Indianapolis

Andrew NordIndianapolis$47K
Qun Ming ZhangIndianapolis$28K
Lindsay YoderIndianapolis$21K
Mackenzie LawsonIndianapolis$15K
Christina RaceIndianapolis$13K
Zara BogenschutzIndianapolis$12K
Ashley WorthingtonIndianapolis$11K
Madison MaloofIndianapolis$10K
Jason BrownIndianapolis$10K
Michaela WehrIndianapolis$10K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →